Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Rapid normalization of platelet counts in patients with refractory thrombocytopenia associated with systemic lupus erythematosus (SLE) following treatment with allogeneic dual-target CD19/BCMA CAR T-cell therapy (QT-019B)

Blood (2025) 146 (Supplement 1): 3031.

https://doi.org/10.1182/blood-2025-3031

Published: 2025

Journal Articles

Inhibition of CPT1A reverses AML1-ETO-induced differentiation blockage by activating BCL-2/MYC signaling and metabolic reprogramming

Shaowei Qiu, Fan Ding, Yu Liu, Haoren Wang, Qing Rao, Runxia Gu, Min Wang, Jianxiang Wang

Blood (2025) 146 (Supplement 1): 3224.

https://doi.org/10.1182/blood-2025-3224

Published: 2025

Journal Articles

Synergistic integration of CAR-T cell pharmacokinetics and NGS-MRD evolution enables precision risk stratification in relapsed/refractory B-cell acute lymphoblastic leukemia

Runxia Gu, Shuning Wei, Shaowei Qiu, Xiaoyuan Gong, Guangji Zhang, Benfa Gong, Qiuyun Fang, Shouyun Li, Kaiqi Liu, Dong Lin, Ying Wang, Chunlin Zhou, Bingcheng LIU, Yingchang Mi, Hui Wei, Jianxiang Wang, Ying Wang

Blood (2025) 146 (Supplement 1): 3366.

https://doi.org/10.1182/blood-2025-3366

Published: 2025

Journal Articles

Modification of post-trogocytosis effects to Enhance CAR-t cell persistence

Jianxiang Wang, Haotian Ma, Heye Yu, Shangshang Wang, Fan Ding, Haoren Wang, Wei Li, Yingxi Xu, Shaowei Qiu, Haiyan Xing, Kejing Tang, Zheng Tian, Qing Rao, Runxia Gu, Min Wang

Blood (2025) 146 (Supplement 1): 810.

https://doi.org/10.1182/blood-2025-810

Published: 2025

Journal Articles

Machine learning-based novel surfaceome classification system for acute myeloid leukemia

Heye Yu, Wenbing Liu, Qianqian Huang, Haotian Ma, Fan Ding, Yingxi Xu, Ying Wang, Qing Rao, Runxia Gu, Min Wang, Shaowei Qiu, Jianxiang Wang

Blood (2025) 146 (Supplement 1): 452.

https://doi.org/10.1182/blood-2025-452

Published: 2025

Journal Articles

Single CAR-t infusion during front-line consolidation induces deep and sustained remission in newly diagnosed adult ph+b- ALL: A prospective phase 2 study

Runxia Gu, Shaowei Qiu, Xiaoyuan Gong, Shuning Wei, Guangji Zhang, Benfa Gong, Qiuyun Fang, Shouyun Li, Kaiqi Liu, Dong Lin, Ying Wang, Chunlin Zhou, Chengcai Guo, Bingcheng LIU, Yingchang Mi, Hui Wei, Ying Wang, Jianxiang Wang

Blood (2025) 146 (Supplement 1): 442.

https://doi.org/10.1182/blood-2025-442

Published: 2025

Journal Articles

Front-line consolidation with CAR-t therapy in newly diagnosed adult ph-negative b-acute lymphoblastic leukemia: Results from a prospective, phase 2 study

Runxia Gu, Shaowei Qiu, Wenbing Liu, Xiaoyuan Gong, Shuning Wei, Guangji Zhang, Benfa Gong, Qiuyun Fang, Shouyun Li, Kaiqi Liu, Dong Lin, Ying Wang, Chunlin Zhou, Chengcai Guo, Bingcheng LIU, Yingchang Mi, Hui Wei, Ying Wang, Jianxiang Wang

Blood (2025) 146 (Supplement 1): 1561.

https://doi.org/10.1182/blood-2025-1561

Published: 2025

Journal Articles

Mapping T-ALL to T Cell Differentiation Trajectory Identifies an ETP-like Subgroup Arrested at an Early Stage of T Cell Development

Heye Yu, Wenbing Liu, Junping Zhang, Leling Xie, Anli Lai, Zheng Tian, Kejing Tang, Haiyan Xing, Wang Ying, Hui Wei, Qing Rao, Runxia Gu, Min Wang, Huijun Wang, Jianxiang Wang, Shaowei Qiu

Blood (2024) 144 (Supplement 1): 1463.

https://doi.org/10.1182/blood-2024-194208

Published: 2024

Journal Articles

CRISPR-Cas9 Screening Identifies Therapeutic Targets for AML1-ETO Positive Leukemia

Chengcai Guo, Yu Liu, Qing Rao, Runxia Gu, Shaowei Qiu, Min Wang, Jianxiang Wang

Blood (2024) 144 (Supplement 1): 2734.

https://doi.org/10.1182/blood-2024-194291

Published: 2024

Journal Articles

Integrative Multi-Omics Analyses Identify a High-Risk Subgroup of Patients with Poor Prognosis in t(8;21) Acute Myeloid Leukemia

Yu Liu, Wenbing Liu, Yihan Mei, Qing Rao, Runxia Gu, Min Wang, Jianxiang Wang, Shaowei Qiu

Blood (2024) 144 (Supplement 1): 328.

https://doi.org/10.1182/blood-2024-194287

Published: 2024

Journal Articles

Improved MRD Clearance By Incorporating Venetoclax into Pediatric-Inspired Regimen in Newly Diagnosed Adolescent and Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia

Xiaoyuan Gong, Qiuyun Fang, Runxia Gu, Shaowei Qiu, Kaiqi Liu, Dong Lin, Chunlin Zhou, Shuning Wei, Guangji Zhang, Benfa Gong, Yuntao Liu, Yan Li, Shouyun Li, Bingcheng Liu, Wang Ying, Hui Wei, Yingchang Mi, Jianxiang Wang

Blood (2024) 144 (Supplement 1): 2812.

https://doi.org/10.1182/blood-2024-199109

Published: 2024

Journal Articles

The Chromatin Accessibility Landscape and Regulatory Network of CD34 Positive Cells in Acute Myeloid Leukemia

Wenbing Liu, Yu Liu, Anli Lai, Runxia Gu, Ying Wang, Qing Rao, Yingchang Mi, Hui Wei, Shaowei Qiu, Min Wang, Jianxiang Wang

Blood (2024) 144 (Supplement 1): 2927.

https://doi.org/10.1182/blood-2024-198599

Published: 2024

Journal Articles

Inotuzumab Ozogamicin Administration in First Remission Results in Profound and Safe Minimal Residual Disease Eradication in Adult Patients with Ph-Negative Acute Lymphoblastic Leukemia: Findings from a Phase 2, Single-Arm Trial

Blood (2024) 144 (Supplement 1): 4199.

https://doi.org/10.1182/blood-2024-200713

Published: 2024

Journal Articles

Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: An Updated Report on the Pivotal Study of Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (r/r B-Cell ALL) in China

Blood (2024) 144 (Supplement 1): 4196.

https://doi.org/10.1182/blood-2024-199983

Published: 2024

Journal Articles

ADGRG1/GPR56 As a Marker of CD8 + Tumor-Reactive T Cells in Acute Myeloid Leukemia

Yihan Mei, Yu Liu, Wenbing Liu, Manling Chen, Qing Rao, Min Wang, Shaowei Qiu, Runxia Gu, Jianxiang Wang

Blood (2024) 144 (Supplement 1): 4289.

https://doi.org/10.1182/blood-2024-194281

Published: 2024

Journal Articles

The Impact of ZNF384 Rearranged on Antigen Editing during Treatment-Specific Selective Pressures in Adult B Cell Acute Lymphoid Leukemia

Runxia Gu, Wenbin Liu, Yihan Mei, Le Li, Chunlin Zhou, Yan Li, Yuntao Liu, Shuning Wei, Dong Lin, Kaiqi Liu, Qiuyun Fang, Xiaoyuan Gong, Benfa Gong, Shaowei Qiu, Bingcheng Liu, Yingchang Mi, Hui Wei, Ying Wang, Jianxiang Wang

Blood (2023) 142 (Supplement 1): 4209.

https://doi.org/10.1182/blood-2023-188950

Published: 2023

Journal Articles

Prognostic Value of MRD By Flow Cytometry in Adolescent and Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Treated with Pediatric-Inspired Regimen: A Post-Hoc Analysis from a Prospective Study of China

Xiaoyuan Gong, Qiuyun Fang, Runxia Gu, Shaowei Qiu, Kaiqi Liu, Dong Lin, Chunlin Zhou, Guangji Zhang, Benfa Gong, Yuntao Liu, Yan Li, Shouyun Li, Bingcheng Liu, Ying Wang, Hui Wei, Yingchang Mi, Jianxiang Wang

Blood (2023) 142 (Supplement 1): 6073.

https://doi.org/10.1182/blood-2023-174856

Published: 2023

Journal Articles

RTK-RAS Signaling Pathway Was Enriched in Rare Acute Myeloid Leukemia Patients with t(16;21)(p11;q22)/ FUS::ERG

Anli Lai, Hui Wei, Ying Wang, Dong Lin, Chunlin Zhou, Bingcheng Liu, Runxia Gu, Yan Li, Shuning Wei, Benfa Gong, Kaiqi Liu, Xiaoyuan Gong, Yuntao Liu, Guangji Zhang, Junping Zhang, Yingchang Mi, Shaowei Qiu, Jianxiang Wang

Blood (2023) 142 (Supplement 1): 5988.

https://doi.org/10.1182/blood-2023-179966

Published: 2023

Journal Articles

IKZF2 Specifically Participates in AML1-ETO Mediated Blockage of Myeloid Differentiation

Yu Liu, Chengcai Guo, Wenbing Liu, Xiaoyu Liu, Qing Rao, Runxia Gu, Shaowei Qiu, Min Wang, Jianxiang Wang

Blood (2023) 142 (Supplement 1): 2750.

https://doi.org/10.1182/blood-2023-179854

Published: 2023

Journal Articles

The Immune Editing Process Reshapes the AML1-ETO Fusion Protein-Induced Pre-Leukemia Microenvironment

Yihan Mei, Manling Chen, Runxia Gu, Shaowei Qiu, Qing Rao, Min Wang, Jianxiang Wang

Blood (2023) 142 (Supplement 1): 5710.

https://doi.org/10.1182/blood-2023-178305

Published: 2023

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Rapid normalization of platelet counts in patients with refractory thrombocytopenia associated with systemic lupus erythematosus (SLE) following treatment with allogeneic dual-target CD19/BCMA CAR T-cell therapy (QT-019B)

Inhibition of CPT1A reverses AML1-ETO-induced differentiation blockage by activating BCL-2/MYC signaling and metabolic reprogramming

Synergistic integration of CAR-T cell pharmacokinetics and NGS-MRD evolution enables precision risk stratification in relapsed/refractory B-cell acute lymphoblastic leukemia

Modification of post-trogocytosis effects to Enhance CAR-t cell persistence

Machine learning-based novel surfaceome classification system for acute myeloid leukemia

Single CAR-t infusion during front-line consolidation induces deep and sustained remission in newly diagnosed adult ph+b- ALL: A prospective phase 2 study

Front-line consolidation with CAR-t therapy in newly diagnosed adult ph-negative b-acute lymphoblastic leukemia: Results from a prospective, phase 2 study

Mapping T-ALL to T Cell Differentiation Trajectory Identifies an ETP-like Subgroup Arrested at an Early Stage of T Cell Development

CRISPR-Cas9 Screening Identifies Therapeutic Targets for AML1-ETO Positive Leukemia

Integrative Multi-Omics Analyses Identify a High-Risk Subgroup of Patients with Poor Prognosis in t(8;21) Acute Myeloid Leukemia

Improved MRD Clearance By Incorporating Venetoclax into Pediatric-Inspired Regimen in Newly Diagnosed Adolescent and Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia

The Chromatin Accessibility Landscape and Regulatory Network of CD34 Positive Cells in Acute Myeloid Leukemia

Inotuzumab Ozogamicin Administration in First Remission Results in Profound and Safe Minimal Residual Disease Eradication in Adult Patients with Ph-Negative Acute Lymphoblastic Leukemia: Findings from a Phase 2, Single-Arm Trial

Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: An Updated Report on the Pivotal Study of Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (r/r B-Cell ALL) in China

ADGRG1/GPR56 As a Marker of CD8 + Tumor-Reactive T Cells in Acute Myeloid Leukemia

The Impact of ZNF384 Rearranged on Antigen Editing during Treatment-Specific Selective Pressures in Adult B Cell Acute Lymphoid Leukemia

Prognostic Value of MRD By Flow Cytometry in Adolescent and Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Treated with Pediatric-Inspired Regimen: A Post-Hoc Analysis from a Prospective Study of China

RTK-RAS Signaling Pathway Was Enriched in Rare Acute Myeloid Leukemia Patients with t(16;21)(p11;q22)/ FUS::ERG

IKZF2 Specifically Participates in AML1-ETO Mediated Blockage of Myeloid Differentiation

The Immune Editing Process Reshapes the AML1-ETO Fusion Protein-Induced Pre-Leukemia Microenvironment

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only